Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Stabilized chlorine dioxide + sodium fluoride is a combination oral care formulation primarily used for the prevention of dental caries and the management of oral hygiene. Stabilized chlorine dioxide serves as an oxidizing agent that targets and disrupts oral biofilms, neutralizes volatile sulfur compounds (VSCs) responsible for halitosis, and exhibits broad-spectrum antimicrobial and antiviral properties. Sodium fluoride provides anticavity benefits by promoting the remineralization of tooth enamel and increasing its resistance to acid-driven demineralization. Developed by Rowpar Pharmaceuticals and marketed under the brand CloSYS, this combination is typically formulated as a toothpaste or oral rinse for topical application in the oral cavity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on stabilized chlorine dioxide + sodium fluoride.